What are the Consequences of Type I Errors in Clinical Trials?
In clinical trials for new cancer treatments, a Type I error might suggest that a new drug is effective when it is not. This can lead to its approval and widespread use, exposing patients to ineffective and potentially harmful treatments. Furthermore, it diverts resources away from more promising therapies.
